Electromed Inc.

Electromed, Inc., is a pharmaceutical company. The Company manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System (SmartVest System) includes its newest generation SmartVest SQL and previous generation SV2100 and related products, to patients with compromised pulmonary function. SmartVest SQL was designed, developed and cleared by the FDA in December of 2013. The SmartVest System has been approved by the United States Food and Drug Administration (FDA) to treat the condition of excess lung secretions. It may be prescribed to patients suffering from cystic fibrosis, chronic obstructive pulmonary disease, muscular dystrophy, post-surgical airway complications and a variety of other diseases and conditions associated with impaired lung and airway capacity. During the second half of fiscal year 30 June, 2014, the Company launched next generation SmartVest System, and the SmartVest SQL to the domestic homecare market.